Lenovo ThinkReality VRX is Now Available in Select Markets Worldwide
Next-level VR headset in a compact form factor with mixed reality capabilities for immersive training,…
Next-level VR headset in a compact form factor with mixed reality capabilities for immersive training,…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or…
A type of artificial intelligence (AI), Deep Learning (DL) technology can advance medical imaging capabilities…
Vancouver, British Columbia–(Newsfile Corp. – May 30, 2023) – Kovo HealthTech Corporation (TSXV: KOVO) (the…
Luxembourg, May 31, 2023 – (ACN Newswire) – Moolec Science SA (NASDAQ: MLEC) a science-based…
TORONTO–(BUSINESS WIRE)–Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), a leader in smart…
Accelerating workload migrations to the cloud for shared customers, with expanded collaboration and new AWS…
Mobilitie was selected by joint venture partners, AEG & Southwest Value Partners, to deliver a…
Lens Control Center simplifies secure Kubernetes deployments CAMPBELL, Calif.–(BUSINESS WIRE)–#Lens—Mirantis, freeing developers to create their…
UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology…
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology…
DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aceragen, Inc. (the “Company”)…
DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aceragen, Inc. (the “Company”)…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage…